JBJ Investment Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$229K Buy
+3,880
New +$192K 0.05% 60
2019
Q3
Sell
-5,871
Closed -$241K 51
2019
Q2
$241K Buy
5,871
+74
+1% +$2.94K 0.09% 39
2019
Q1
$234K Buy
+5,797
New +$232K 0.09% 31

Other funds holding PFE

JBJ Investment Partners's PFE Position: Q4 2021 in Review

JBJ Investment Partners opened a new position in Pfizer (PFE) in Q4 2021: 3,880 shares worth $229K. The stake represents 0.05% of the portfolio and ranks #60 among its holdings. This is a return to the name: JBJ Investment Partners previously reported a position in PFE as recently as Q2 2019.

JBJ Investment Partners first reported a position in PFE in Q1 2019 and has held it in 3 quarters since. The position peaked at $241K in Q2 2019. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

  • JBJ Investment Partners held 3,880 shares of Pfizer worth $229K as of Q4 2021.
  • Pfizer was a new JBJ Investment Partners position in Q4 2021.
  • Pfizer made up 0.05% of JBJ Investment Partners's portfolio in Q4 2021, its #60 holding.
  • JBJ Investment Partners first reported a position in Pfizer in Q1 2019 and has held it in 3 quarters since.
  • JBJ Investment Partners's Pfizer position peaked at $241K in Q2 2019.
  • 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on JBJ Investment Partners's 13F filing for Q4 2021, filed 8 Feb 2022.